Picard Medical Reports Q2 Revenue Increase to $3.0 Million
Picard Medical (NYSE: PMI) reported second-quarter revenue of approximately $3.0 million for the three months ended June 30, representing a 39% increase compared to ~$2.1 million in the same period last year. The growth was primarily driven by an uptick in U.S. sales, which rose by around $0.8 million. The company also reported gross profit of approximately $0.6 million for Q2 2025. While no guidance or forward-looking statements were provided in the release, the revenue increase suggests improved performance and market traction during the quarter.
Tickers: $PMI
Topics: gross_profit revenue_growth